Landscape Capital Management
ASLN

Landscape Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Landscape Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,407
Closed -$43.5K – 1032
2023
Q4 		$43.5K Buy
+10,407
New +$78.5K ﹤0.01% 781

Other funds holding ASLN

BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Velan Capital Investment Management
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Shay Capital
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Marex Group
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

Landscape Capital Management's ASLN Position: Q1 2024 in Review

Landscape Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2024, closing a stake of 10,407 shares — an estimated $43.5K sold.

Landscape Capital Management first reported a position in ASLN in Q4 2023 and held it in 1 quarter. The position peaked at $43.5K in Q4 2023. 22 funds tracked by Wall St. Rank hold ASLN as of Q1 2024.

  • Landscape Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Landscape Capital Management sold 10,407 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2024, an estimated $43.5K.
  • Landscape Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2023 and held it in 1 quarter.
  • Landscape Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $43.5K in Q4 2023.
  • 22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2024.

Based on Landscape Capital Management's 13F filing for Q1 2024, filed 9 May 2024.